Is This the End of Medical Marijuana?

By Sean Williams September 14, 2014

Marijuana perception among U.S. citizens is rapidly changing. For the first time ever last year, according to a poll from Gallup, more respondents were in favor of legalizing marijuana than were opposed to its legalization. Yet, there are still few more controversial issues than whether or not to allow marijuana to be used for medical purposes.

For medical marijuana supporters there’s plenty of clinical supportive evidence from companies like GW Pharmaceuticals (NASDAQ: GWPH ) , which incorporates internally discovered cannabinoids derived from cannabis plants into its pipeline products. GW’s initial clinical studies have suggested cannabinoids could have positive effects with regard to treating cancer pain as well as adult and pediatric epilepsy. As further proof, Sativex, the company’s drug designed to reduce spasticity associated with multiple sclerosis, is approved in more than a dozen countries around the world (the U.S. is not one of those countries).

http://www.fool.com/investing/general/2014/09/14/is-this-the-end-of-medical-marijuana.aspx